Standard Life Aberdeen plc lessened its position in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 7.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 556,874 shares of the pharmacy operator’s stock after selling 42,860 shares during the period. Standard Life Aberdeen plc’s holdings in Walgreens Boots Alliance were worth $32,834,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in WBA. State Street Corp lifted its stake in shares of Walgreens Boots Alliance by 0.7% during the 3rd quarter. State Street Corp now owns 46,664,748 shares of the pharmacy operator’s stock worth $2,581,027,000 after buying an additional 338,005 shares during the last quarter. Caisse DE Depot ET Placement DU Quebec lifted its stake in shares of Walgreens Boots Alliance by 1.8% during the 4th quarter. Caisse DE Depot ET Placement DU Quebec now owns 14,484,065 shares of the pharmacy operator’s stock worth $853,980,000 after buying an additional 257,400 shares during the last quarter. American International Group Inc. lifted its stake in shares of Walgreens Boots Alliance by 781.9% during the 4th quarter. American International Group Inc. now owns 5,511,875 shares of the pharmacy operator’s stock worth $324,980,000 after buying an additional 4,886,896 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its stake in shares of Walgreens Boots Alliance by 3.5% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 3,959,827 shares of the pharmacy operator’s stock worth $233,472,000 after buying an additional 134,674 shares during the last quarter. Finally, UBS Asset Management Americas Inc. lifted its stake in shares of Walgreens Boots Alliance by 3.2% during the 4th quarter. UBS Asset Management Americas Inc. now owns 3,604,466 shares of the pharmacy operator’s stock worth $212,519,000 after buying an additional 110,511 shares during the last quarter. 59.20% of the stock is owned by institutional investors.

WBA traded up $4.23 during trading on Thursday, reaching $45.67. 11,093,688 shares of the company’s stock were exchanged, compared to its average volume of 10,397,502. Walgreens Boots Alliance Inc has a one year low of $40.52 and a one year high of $64.50. The company has a current ratio of 0.66, a quick ratio of 0.31 and a debt-to-equity ratio of 1.34. The stock has a market capitalization of $40.09 billion, a PE ratio of 11.22, a price-to-earnings-growth ratio of 1.18 and a beta of 0.86. The firm has a fifty day moving average price of $49.46 and a two-hundred day moving average price of $54.69.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Wednesday, January 8th. The pharmacy operator reported $1.37 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $1.40 by ($0.03). The firm had revenue of $34.34 billion during the quarter, compared to analyst estimates of $34.45 billion. Walgreens Boots Alliance had a return on equity of 21.76% and a net margin of 2.69%. The firm’s revenue for the quarter was up 1.6% on a year-over-year basis. During the same quarter last year, the firm posted $1.46 EPS. Sell-side analysts expect that Walgreens Boots Alliance Inc will post 5.84 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, March 12th. Shareholders of record on Wednesday, February 19th were issued a dividend of $0.458 per share. The ex-dividend date of this dividend was Tuesday, February 18th. This represents a $1.83 annualized dividend and a yield of 4.01%. Walgreens Boots Alliance’s payout ratio is 30.55%.

A number of analysts have recently issued reports on the stock. SunTrust Banks raised their target price on shares of Walgreens Boots Alliance from $58.00 to $60.00 and gave the stock a “hold” rating in a research note on Wednesday, December 18th. Cowen cut their target price on shares of Walgreens Boots Alliance from $60.00 to $54.00 and set a “market perform” rating for the company in a research note on Monday, February 10th. ValuEngine cut shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Tuesday, March 3rd. TheStreet cut shares of Walgreens Boots Alliance from a “b-” rating to a “c+” rating in a research note on Tuesday, February 25th. Finally, Mizuho restated a “hold” rating and set a $59.00 target price on shares of Walgreens Boots Alliance in a research note on Thursday, January 9th. Five investment analysts have rated the stock with a sell rating and fourteen have issued a hold rating to the company. The stock has a consensus rating of “Hold” and an average price target of $57.33.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Further Reading: What is the Current Ratio?

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.